Technology | Breast Imaging | January 21, 2019

LOCalizer Implantable Tag Cleared for Long-Term Breast Lesion Placement

Wire-free lesion localization marker can now be implanted for more than 30 days, creating more flexibility for providers and patients during breast surgeries

LOCalizer Implantable Tag Cleared for Long-Term Breast Lesion Placement

January 21, 2019 –  Hologic announced that the U.S. Food and Drug Administration (FDA) has cleared the LOCalizer radiofrequency identification (RFID) marker for long-term placement. With this clearance, the marker can now be implanted more than 30 days prior to a breast-conserving surgery, providing even greater flexibility and convenience to patients and providers.

Initially cleared by the FDA in 2017, LOCalizer is a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. The system was designed to replace the traditional wire-guided localization method, which requires placement of a wire the day of surgery. It is manufactured by Health Beacons Inc. and is exclusively distributed by Hologic.

Following placement days ahead of surgery, the miniature implantable tag can be detected by a portable, handheld reader that indicates the location and distance to the lesion, enabling the surgeon to pinpoint the correct area of breast tissue for removal. Each tag also features a unique identification number that is displayed on the reader. This improved workflow is designed to help reduce scheduling and logistical hurdles for care teams, and aims to deliver added convenience for an enhanced patient experience.

Dona Hobart, M.D., breast surgeon and medical director of the Center for Breast Health at Carroll Hospital in Maryland, has been using the LOCalizer system for almost a year. “The LOCalizer system is designed to address the challenges of other localization methods as well as enable surgeries tailored appropriately to each patient, which is a positive advancement in patient care,” she said.

For more information: www.hologic.com

Related Content

Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
 Volpara Solutions Launches Next-Generation VolparaDensity Software to Support SmartCurve Paddles
Technology | Breast Density | January 31, 2019
Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in...
QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids
News | Ultrasound Women's Health | January 30, 2019
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission
Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Feature | Breast Imaging | January 30, 2019 | By Jeff Zagoudis
The importance of early detection of...
Wefight Unveils Vik Breast Chatbot at CES 2019
News | Artificial Intelligence | January 25, 2019
French startup company Wefight unveiled the English version of its Vik Breast chatbot for breast cancer patients at the...